ARCHIVES

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Weak Structure, Deficiencies, Cited In Dana-Farber Reviews

November 3, 1995

RFPs Available

May 5, 2000

In Brief: DCE Board Nixes NIH Intramural Postdoctural Program Magazines Rapped For Cigarette Ads

July 13, 1984

Correction: Appropriations Reports Included Language of Minorities and Underserved

October 15, 1999

Nobel In Chemistry For Work Linking Carbon Atoms

October 8, 2010

UCLA, NYU Get Money, Near comprehensive Identification

May 30, 1975